Health Care & Life Sciences » Biotechnology | Selecta Biosciences Inc.

Selecta Biosciences Inc.

Selecta Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.52
Market Cap
$77.93 M
Shares Outstanding
44.79 M
Public Float
33.64 M

Profile

Address
480 Arsenal Way
Watertown Massachusetts 02472
United States
Employees -
Website http://www.selectabio.com
Updated 07/08/2019
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The firm produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Its proprietary pipeline includes SVP-enabled enzyme, oncology, and gene therapies.

Financials

View All
Created with Highcharts 5.0.14Selecta Biosciences Inc.Net Income. Fiscal year is January-December. All values USD Thousands.12 88012 88025 17425 17436 21036 21065 32165 32165 33665 33620142015201620172018020k40k60k80k
Created with Highcharts 5.0.14Selecta Biosciences Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.3 0403 0406 0116 0118 0838 0832072079039032014201520162017201802k4k6k8k10k

Omid C. Farokhzad
Chairman
Werner Cautreels
President, Chief Executive Officer & Director